Literature DB >> 26891108

The clinical picture of Alzheimer's disease in the decade before diagnosis: clinical and biomarker trajectories.

Karen Ritchie1, Isabelle Carrière, Claudine Berr, Hélène Amieva, Jean-François Dartigues, Marie-Laure Ancelin, Craig W Ritchie.   

Abstract

OBJECTIVE: Increasing evidence suggests that Alzheimer's disease begins at least a decade before the diagnosis of dementia. Earlier identification of the disease will have important implications for intervention; however, current models of preclinical changes are theoretical and require verification from empirical observations. Furthermore, these models have not incorporated psychiatric features.
METHOD: Clinical and biological markers were examined at baseline (1999-2001) in 9,076 people aged 65 years and older. A nested case-control study included 830 cases with Alzheimer's disease diagnosed by DSM-IV criteria during the 10-year follow-up and twice as many controls. By taking the distance between baseline and diagnosis as the length of the preclinical period, disease marker trajectories were estimated using nonparametric locally weighted smoothing analysis.
RESULTS: Significant differences for the cases compared to the controls were observed on both intercept and slope for truncated amyloid β40 (P = .006; P = .003, respectively), C-reactive protein (P = .03; P = .05), verbal fluency (P < .0001; P < .0001), visual recall (P < .0001; P = .007), and hippocampal volume (P = .0002; P = .04) and on the slope only for truncated amyloid β42 (P = .01). The cases showed higher levels of depressive symptoms (P = .003), which remained stable over the 10 years to diagnosis.
CONCLUSIONS: As hypothesized by existing theoretical models, changes in plasma amyloid β levels, hippocampal atrophy, cognitive loss, and C-reactive protein are already observed up to 10 years before diagnosis. An acceleration in cognitive decline appears to follow a significant increase in amyloid accumulation, and depressive symptomatology remains at a constantly higher level. Overall, clinical and biological markers do not follow the same trajectories; the clinical picture changes according to distance from dementia. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26891108     DOI: 10.4088/JCP.15m09989

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

Review 1.  Anosognosia in Dementia.

Authors:  Robert S Wilson; Joel Sytsma; Lisa L Barnes; Patricia A Boyle
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

2.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

3.  Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

Authors:  Marilyn Albert; Yuxin Zhu; Abhay Moghekar; Susumu Mori; Michael I Miller; Anja Soldan; Corinne Pettigrew; Ola Selnes; Shanshan Li; Mei-Cheng Wang
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

4.  Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer's Disease.

Authors:  Yana Blinkouskaya; Johannes Weickenmeier
Journal:  Front Mech Eng       Date:  2021-07-19

5.  Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies.

Authors:  Joanne Ryan; Peter Fransquet; Jo Wrigglesworth; Paul Lacaze
Journal:  Front Public Health       Date:  2018-06-19

6.  Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment.

Authors:  Katharina Klink; Urs Jaun; Andrea Federspiel; Marina Wunderlin; Charlotte E Teunissen; Claus Kiefer; Roland Wiest; Frank Scharnowski; Ronald Sladky; Amelie Haugg; Lydia Hellrung; Jessica Peter
Journal:  BMC Psychiatry       Date:  2021-02-09       Impact factor: 3.630

7.  Systemic inflammation as a moderator between sleep and incident dementia.

Authors:  Andrée-Ann Baril; Alexa S Beiser; Susan Redline; Emer R McGrath; Hugo J Aparicio; Daniel J Gottlieb; Sudha Seshadri; Matthew P Pase; Jayandra J Himali
Journal:  Sleep       Date:  2021-02-12       Impact factor: 6.313

8.  Depressive Symptoms in the Elderly-An Early Symptom of Dementia? A Systematic Review.

Authors:  Wietse Wiels; Chris Baeken; Sebastiaan Engelborghs
Journal:  Front Pharmacol       Date:  2020-02-07       Impact factor: 5.810

9.  Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study.

Authors:  Joanna Norton; Isabelle Carrière; Karine Pérès; Audrey Gabelle; Claudine Berr; Karen Ritchie; Marie-Laure Ancelin
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

10.  Comparison of Cox proportional hazards regression and generalized Cox regression models applied in dementia risk prediction.

Authors:  Jantje Goerdten; Isabelle Carrière; Graciela Muniz-Terrera
Journal:  Alzheimers Dement (N Y)       Date:  2020-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.